About BioGenesis
Who We Are
BioGenesis is a leading biotechnology company dedicated to advancing nucleic acid therapeutics and protein engineering. Founded in 2018 and headquartered in Shanghai Zhangjiang Hi-Tech Park, we have grown from a small research team to a comprehensive biopharmaceutical service provider.
Our Mission
To accelerate the development of nucleic acid drugs and protein therapeutics through innovative technology platforms, enabling breakthrough treatments for patients worldwide.
Our Vision
To become the most trusted partner for biopharmaceutical companies and research institutions in nucleic acid and protein engineering, driving the next generation of precision medicine.
Core Values
- Scientific Excellence: Rigorous research methodology and cutting-edge technology
- Innovation: Continuous investment in R&D and novel platform development
- Collaboration: Open partnerships with academia and industry
- Quality: GMP-compliant manufacturing with comprehensive quality control
- Integrity: Transparent communication and ethical business practices
Technology Platforms
Our integrated technology platforms span the full spectrum of nucleic acid and protein engineering:
mRNA Platform
End-to-end mRNA design, optimization, and synthesis capabilities from research to GMP-grade production.
siRNA Platform
AI-powered siRNA design and high-throughput screening for efficient gene silencing.
Enzyme Platform
Premium enzyme products and custom enzyme engineering services.
Glycoengineering Platform
Advanced protein glycosylation engineering and characterization services.
Certifications & Quality
- GMP-certified manufacturing facility
- ISO 9001:2015 quality management system
- ISO 13485:2016 medical device quality management
Core Team
Led by world-class scientists with decades of experience in nucleic acid therapeutics and protein engineering
Our Journey
Key milestones in BioGenesis's growth and innovation
Company Founded
BioGenesis was established in Shanghai with a mission to advance nucleic acid therapeutics.
First mRNA Product Launch
Launched our first commercial mRNA synthesis service for research customers.
Series A Funding
Closed Series A funding of $20M to expand R&D capabilities and team.
siRNA Platform Launch
Introduced our AI-powered siRNA design and screening platform.
GMP Facility Certified
Achieved GMP certification for our nucleic acid manufacturing facility.
New R&D Center
Opened new 5,000 sqm R&D laboratory in Shanghai Zhangjiang Hi-Tech Park.
News & Publications
Stay updated with our latest company news and academic achievements
Join Us
We are always looking for talented scientists and professionals to join our team. If you are passionate about advancing biotechnology, we want to hear from you.
View Open Positions β